Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to.
(2022-08-31 | NDAQ:OCEA) Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research.
In the latest canceled SPAC merger, cryptocurrency miner VCV Digital Technology and special purpose acquisition company Fortune Rise Acquisition Corp. have scrapped tie-up plans that would have taken VCV public valued at about $294 million, according to a regulatory filing Wednesday.